auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Purpose
This Project aims at establishing a current Good Manufacturing Practices (cGMP)-compliant platform to manufacture clinical grade lentiviral vectors (including production, purification and quality control) at the Centre of Excellence for Cellular Therapy (CETC) of Hôpital Maisonneuve-Rosemont. It builds on the capacity of the CETC, the only fully operational cGMP-compliant cell therapy facility in Canada, to generate viral vectors of clinical and commercial grade at the 50L scale.
Centre for Commercialization of Cancer Immunotherapy × Unknown
4 grants totalling $3.7M
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
1,000 grants totalling $348.9M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Quantum Valley Ideas Laboratories | $1.2M | Collaborative Science, Technology and In... |
| Centre for Commercialization of Cancer Immunotherapy | $1.0M | Collaborative Science, Technology and In... |
| Centre for Commercialization of Cancer Immunotherapy | $1.0M | Collaborative Science, Technology and In... |
| Mitacs inc. | $1.0M | Collaborative Science, Technology and In... |
| Mitacs inc. | $1.0M | Collaborative Science, Technology and In... |